Bannerbild German Brest Group

SABCS 2019: Effects of capecitabine in neo-/adjuvant chemotherapy

12.12.2019

A meta-analysis of individual patient data from 12 randomized trials including 15,457 patients. Presented as SABCS 2019.

/wAssets/docs/events-vortraege/2019_SABCS-Capecitabine.pdf

News

GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd